News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
450,536 Results
Type
Article (28211)
Company Profile (120)
Press Release (422202)
Multimedia
Podcasts (20)
Webinars (10)
Section
Business (123741)
Career Advice (1499)
Deals (24763)
Drug Delivery (58)
Drug Development (58864)
Employer Resources (65)
FDA (10871)
Job Trends (9851)
News (220928)
Policy (19657)
Tag
Academia (1490)
Accelerated approval (10)
Adcomms (10)
Allergies (73)
Alliances (27288)
ALS (87)
Alzheimer's disease (966)
Antibody-drug conjugate (ADC) (98)
Approvals (11003)
Artificial intelligence (187)
Autoimmune disease (26)
Automation (9)
Bankruptcy (196)
Best Places to Work (7907)
BIOSECURE Act (5)
Biosimilars (74)
Biotechnology (89)
Bladder cancer (93)
Brain cancer (26)
Breast cancer (318)
Cancer (2455)
Cardiovascular disease (188)
Career advice (1293)
Career pathing (15)
CAR-T (136)
CDC (10)
Cell therapy (378)
Cervical cancer (19)
Clinical research (49824)
Collaboration (669)
Company closure (3)
Compensation (453)
Complete response letters (19)
COVID-19 (1705)
CRISPR (41)
C-suite (248)
Cystic fibrosis (94)
Data (3013)
Decentralized trials (2)
Denatured (2)
Depression (69)
Diabetes (267)
Diagnostics (4066)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (95)
Drug pricing (73)
Drug shortages (10)
Duchenne muscular dystrophy (123)
Earnings (64811)
Editorial (29)
Employer branding (12)
Employer resources (63)
Events (73314)
Executive appointments (442)
FDA (12474)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (588)
Gene editing (94)
Generative AI (17)
Gene therapy (281)
GLP-1 (539)
Government (2415)
Grass and pollen (3)
Guidances (317)
Healthcare (11782)
HIV (35)
Huntington's disease (17)
IgA nephropathy (40)
Immunology and inflammation (113)
Immuno-oncology (7)
Indications (42)
Infectious disease (1835)
Inflammatory bowel disease (120)
Inflation Reduction Act (6)
Influenza (53)
Intellectual property (111)
Interviews (241)
IPO (13132)
IRA (30)
Job creations (2268)
Job search strategy (1104)
Kidney cancer (12)
Labor market (42)
Layoffs (303)
Leadership (9)
Legal (4238)
Liver cancer (46)
Longevity (7)
Lung cancer (357)
Lymphoma (191)
Machine learning (11)
Management (20)
Manufacturing (269)
MASH (81)
Medical device (8171)
Medtech (8180)
Mergers & acquisitions (12337)
Metabolic disorders (642)
Multiple sclerosis (88)
NASH (12)
Neurodegenerative disease (92)
Neuropsychiatric disorders (24)
Neuroscience (1516)
NextGen: Class of 2025 (3677)
Non-profit (2460)
Now hiring (20)
Obesity (295)
Opinion (122)
Ovarian cancer (91)
Pain (103)
Pancreatic cancer (101)
Parkinson's disease (132)
Partnered (11)
Patents (247)
Patient recruitment (173)
Peanut (35)
People (28119)
Pharmaceutical (29)
Pharmacy benefit managers (6)
Phase I (14963)
Phase II (21832)
Phase III (16957)
Pipeline (2033)
Policy (107)
Postmarket research (2096)
Preclinical (6099)
Press Release (57)
Prostate cancer (125)
Psychedelics (26)
Radiopharmaceuticals (175)
Rare diseases (359)
Real estate (3573)
Recruiting (30)
Regulatory (14961)
Reports (22)
Research institute (1292)
Resumes & cover letters (234)
Rett syndrome (9)
RNA editing (3)
RSV (37)
Schizophrenia (76)
Series A (88)
Series B (60)
Service/supplier (6)
Sickle cell disease (44)
Special edition (14)
Spinal muscular atrophy (123)
Sponsored (20)
Startups (1941)
State (1)
Stomach cancer (9)
Supply chain (42)
Tariffs (42)
The Weekly (17)
Vaccines (538)
Venture capital (35)
Weight loss (170)
Women's health (29)
Worklife (7)
Date
Last 7 days (379)
Last 30 days (1644)
Last 365 days (22094)
2025 (15098)
2024 (24421)
2023 (26936)
2022 (33208)
2021 (36174)
2020 (34451)
2019 (28212)
2018 (20921)
2017 (19859)
2016 (18369)
2015 (22363)
2014 (15905)
2013 (11867)
2012 (12790)
2011 (13757)
2010 (12092)
Location
Africa (557)
Alabama (60)
Alaska (1)
Arizona (156)
Arkansas (4)
Asia (25182)
Australia (4165)
California (6029)
Canada (1604)
China (516)
Colorado (229)
Connecticut (270)
Delaware (174)
Europe (58574)
Florida (948)
Georgia (190)
Idaho (25)
Illinois (473)
India (25)
Indiana (302)
Iowa (13)
Japan (166)
Kansas (76)
Kentucky (16)
Louisiana (10)
Maine (65)
Maryland (725)
Massachusetts (4178)
Michigan (122)
Minnesota (291)
Mississippi (3)
Missouri (51)
Montana (12)
Nebraska (6)
Nevada (69)
New Hampshire (35)
New Jersey (1906)
New Mexico (7)
New York (1790)
North Carolina (832)
North Dakota (3)
Northern California (2787)
Ohio (160)
Oklahoma (6)
Oregon (12)
Pennsylvania (1329)
Puerto Rico (14)
Rhode Island (21)
South America (751)
South Carolina (33)
South Dakota (1)
Southern California (2342)
Tennessee (84)
Texas (975)
United States (21955)
Utah (177)
Virginia (156)
Washington D.C. (48)
Washington State (548)
West Virginia (4)
Wisconsin (41)
450,536 Results for "10".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Now Hiring
10 Companies Hiring in San Francisco
Looking for a biopharma job in San Francisco? Check out the
BioSpace
list of 10 companies hiring life sciences professionals like you.
May 15, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Cantargia Closes the Acquisition of CAN10 by Otsuka
September 11, 2025
·
3 min read
Press Releases
Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders
September 5, 2025
·
3 min read
Press Releases
CEL-SCI Announces Closing of $10 Million Public Offering
September 1, 2025
·
3 min read
Press Releases
CEL-SCI Announces Pricing of $10 Million Public Offering
August 28, 2025
·
3 min read
Press Releases
10x Genomics to Acquire Scale Biosciences
August 8, 2025
·
5 min read
Press Releases
Celularity Receives Nasdaq Notice Regarding Form 10-Q
August 24, 2025
·
4 min read
Press Releases
Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10
September 4, 2025
·
4 min read
Press Releases
MadSci Announces $10 Million Oversubscribed Seed Financing to Advance Smart Technology for Neurologic Conditions
September 9, 2025
·
3 min read
FDA
Prasad Back at CBER After 10-Day California ‘Vacation’
After exiting the FDA less than two weeks ago for unclear reasons, Vinay Prasad is once again director of the Center for Biologics Evaluation and Research, HHS confirmed to several outlets Saturday.
August 9, 2025
·
2 min read
·
Heather McKenzie
1 of 45,054
Next
